A new peer-reviewed study published in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.
May 23, 2024
Study in JAHA Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight
May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that…
Read More
The REVEALPLAQUE trial was a large, global prospective study which enrolled 258 patients across 15 sites in the U.S. and Japan
May 23, 2024
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced…
Read More
Real-life data highlights need for patient-centered management of unhealthy cholesterol 
May 23, 2024
Real-life Data Highlights Need for Patient-centered Management of Unhealthy Cholesterol
May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first…
Read More
New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC)
May 22, 2024
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical…
Read More
Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis
May 22, 2024
Voiant and Thirona Announce Commercial Partnership for Full Scope Services in Imaging-based Clinical Trials for Pulmonary Diseases
May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership,…
Read More
Artificial intelligence (AI)-driven health technology company, Anumana, which developed the FDA-approved ECG-AI LEF algorithm, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System.
May 21, 2024
Cardiac Care AI Company, Anumana, Announces Receipt of ISO 13485 Certification
May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and…
Read More
Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa
May 21, 2024
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular…
Read More
Correlation between transcriptomic age and other epigenetic aging predictors
May 21, 2024
Association of Inflammatory and Metabolic Biomarkers and Accelerated Aging in Cardiac Catheterization Patients
May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-…
Read More
Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification
May 20, 2024
Ochsner Medical Center-Baton Rouge earns Acute Stroke Ready Certification from Joint Commission
May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the…
Read More
Cardiologist Brendan Carry, MD, and a team of Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. Image courtesy: Geisinger Medical Center/Mark Dastrup
May 20, 2024
Geisinger Enrolls First Patient in Amyloid Cardiomyopathy Trial
May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians…
Read More
Early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB), according to a study conducted by a research team led by Yong-Mei Cha, MD, cardiac electrophysiologist at Mayo Clinic, Rochester, MN, presented during the Heart Rhythm Society meeting, HRS 2024.
May 18, 2024
Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure
May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and…
Read More
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker
May 18, 2024
MODULAR ATP Study of the mCRM System Meets Primary Safety and Efficacy Endpoints
May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal…
Read More
During the Heart Rhythm Society (HRS) annual meeting, HRS 2024, findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), for patients with atrial fibrillation (AF) were presented. Learn more of the late-breaking science from the FARADISE, admIRE Study, and Advent Trial here.
May 18, 2024
Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment
May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety…
Read More
Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs
May 17, 2024
Philips Presents Study Results at Heart Rhythm Annual Meeting Demonstrating Benefits of its AI-powered Cardiac Monitoring Solutions
May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results…
Read More
Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions
May 17, 2024
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes/Heart Failure
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled…
Read More
Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling medical teams to intervene and avoid hospitalization.
May 17, 2024
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
May 17, 2024 —  Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it…
Read More
NIH-funded study suggests addressing these factors could reduce health disparities
May 16, 2024
Adverse Social Determinants of Health Linked to Treatment-resistant Hypertension in Black Americans
May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced…
Read More
A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia
May 16, 2024
Improving Life Quality in Chronic Limb-Threatening Ischemia Through Revascularization
May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive…
Read More
Researcher presents findings at European Stroke Organization Conference
May 16, 2024
University of Cincinnati Study Finds Severe Ischemic Strokes are Rare in Patient Population
May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic…
Read More
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
May 16, 2024
New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now